| pubmed-article:17510796 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C2700615 | lld:lifeskim |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C0425358 | lld:lifeskim |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C1705258 | lld:lifeskim |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C0241910 | lld:lifeskim |
| pubmed-article:17510796 | lifeskim:mentions | umls-concept:C0122040 | lld:lifeskim |
| pubmed-article:17510796 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17510796 | pubmed:dateCreated | 2008-1-24 | lld:pubmed |
| pubmed-article:17510796 | pubmed:abstractText | Our goal was to determine if HLA DRB1*13 is associated with autoimmune hepatitis in North American patients. Two hundred and ten adults with definite type 1 autoimmune hepatitis were typed by DNA-based techniques, and the frequency of HLA DRB1*13 in patients without DRB1*03 and DRB1*04 was compared to that in 396 patients with eight other chronic liver diseases and 102 normal individuals. HLA DRB1*13 occurred more commonly in the autoimmune patients who lacked DRB1*03 and DRB1*04 than normal subjects who were similarly restricted (56% vs. 27%, P = 0.007). The frequency of HLA DRB1*13 was higher in autoimmune patients without DRB1*03 and DRB1*04 than in patients with other chronic liver diseases who were similarly restricted (59% vs. 32%, P = 0.01). Only patients with primary sclerosing cholangitis had a comparable occurrence of HLA DRB1*13. In conclusion, HLA DRB1*13 may be a genetic risk factor for some white North American patients with type 1 autoimmune hepatitis. | lld:pubmed |
| pubmed-article:17510796 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17510796 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17510796 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17510796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17510796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17510796 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17510796 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17510796 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17510796 | pubmed:issn | 0163-2116 | lld:pubmed |
| pubmed-article:17510796 | pubmed:author | pubmed-author:CzajaAlbert... | lld:pubmed |
| pubmed-article:17510796 | pubmed:author | pubmed-author:CarpenterHers... | lld:pubmed |
| pubmed-article:17510796 | pubmed:author | pubmed-author:MooreS... | lld:pubmed |
| pubmed-article:17510796 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17510796 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:17510796 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17510796 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17510796 | pubmed:pagination | 522-8 | lld:pubmed |
| pubmed-article:17510796 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:meshHeading | pubmed-meshheading:17510796... | lld:pubmed |
| pubmed-article:17510796 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:17510796 | pubmed:articleTitle | HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients. | lld:pubmed |
| pubmed-article:17510796 | pubmed:affiliation | Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street S.W, Rochester, MN 55905, USA. czaja.albert@mayo.edu | lld:pubmed |
| pubmed-article:17510796 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:3123 | entrezgene:pubmed | pubmed-article:17510796 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17510796 | lld:entrezgene |
| lhgdn:association:33206 | lhgdn:found_in | pubmed-article:17510796 | lld:lhgdn |
